CapiThera Ltd, a spin-off from the Swiss specialty pharmaceutical company Curatis AG (www.curatis.com), is “dedicated to the development and commercialization of novel medicines for the prevention and treatment of severe forms of headache". The company has offices in Switzerland (operations) and in the United Kingdom (administration).